T Cell-Specific Knockout of STAT3 Ameliorates Dextran Sulfate Sodium-Induced Colitis by Reducing the Inflammatory Response
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Signal transducer and activator of transcription 3 (STAT3) has a crucial role in various autoimmune disorders including, inflammatory bowel disease (IBD). Our previous study demonstrated that STAT3 activation by IL-6 in colonic epithelial cells exacerbates experimental ulcerative colitis. Activated T lymphocytes are also found in ulcerative colitis patients with intestinal inflammation, but the role of STAT3 in T cells remains elusive. To determine the STAT3 function of T cells in intestinal inflammation, we generated T cell-specific STAT3 knockout (KO) mice and used dextran sulfate sodium (DSS) to induce colitis. In this study, we demonstrated that T cell-specific STAT3 deletion alleviated DSS-induced colitis in mice, resulting in reduced histological scores and myeloperoxidase (MPO) activity. Importantly, the population of T cells in the spleen and lymph nodes was significantly decreased in the control and DSS-induced groups of STAT3 KO mice. In addition, STAT3 deficiency in T cells markedly reduced the production of interferon (IFN)-γ, IL-6, and IL-17A, whereas IL-10 secretion was increased. Collectively, the results suggest that STAT3 in T cells may be a therapeutic target in ulcerative colitis by balancing the immune response through T cell homeostasis.
Abstract
Signal transducer and activator of transcription 3 (STAT3) has a crucial role in various autoimmune disorders including, inflammatory bowel disease (IBD). Our previous study demonstrated that STAT3 activation by IL-6 in colonic epithelial cells exacerbates experimental ulcerative colitis. Activated T lymphocytes are also found in ulcerative colitis patients with intestinal inflammation, but the role of STAT3 in T cells remains elusive. To determine the STAT3 function of T cells in intestinal inflammation, we generated T cell-specific STAT3 knockout (KO) mice and used dextran sulfate sodium (DSS) to induce colitis. In this study, we demonstrated that T cell-specific STAT3 deletion alleviated DSS-induced colitis in mice, resulting in reduced histological scores and myeloperoxidase (MPO) activity. Importantly, the population of T cells in the spleen and lymph nodes was significantly decreased in the control and DSS-induced groups of STAT3 KO mice. In addition, STAT3 deficiency in T cells markedly reduced the production of interferon (IFN)-γ, IL-6, and IL-17A, whereas IL-10 secretion was increased. Collectively, the results suggest that STAT3 in T cells may be a therapeutic target in ulcerative colitis by balancing the immune response through T cell homeostasis.
참고문헌 (33)
- Cader MZ, "Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation", Gut, 62, pp.1653~1664 (2013)[DOI]
- Xu XR, "Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease", World J Gastroenterol, 20, pp.3255~3264 (2014)[DOI]
- McGhee JR, "Inside the mucosal immune system", PLoS Biol, 10, pp.e1001397~ (2012)[DOI]
- Harrison OJ, "Regulatory T cells and immune tolerance in the intestine", Cold Spring Harb Perspect Biol, 5, pp.a018341~ (2013)
- Hisamatsu T, "The role of t-cell subsets in chronic inflammation in celiac disease and inflammatory bowel disease patients: More common mechanisms or more differences?", Inflamm Intest Dis, 1, pp.52~62 (2016)[DOI]
- Zenewicz LA, "CD4 T-cell differentiation and inflammatory bowel disease", Trends Mol Med, 15, pp.199~207 (2009)[DOI]
- Park SG, "T regulatory cells maintain intestinal homeostasis by suppressing <TEX>${\gamma}{\delta}$<", TEX> T cells, 2010, pp.33, 791~803
- Sartor RB, "Cytokines in intestinal inflammation: pathophysiological and clinical considerations", Gastroenterology, 106, pp.533~539 (1994)[DOI]
- Sanchez-Munoz F, "Role of cytokines in inflammatory bowel disease", World J Gastroenterol, 14, pp.4280~4288 (2008)[DOI]
- Neurath MF, "Cytokines in inflammatory bowel disease", Nat Rev Immunol, 14, pp.329~342 (2014)[DOI]
- Muzes G, "Changes of the cytokine profile in inflammatory bowel diseases", World J Gastroenterol, 18, pp.5848~5861 (2012)[DOI]
- Ito R, "Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice", Clin Exp Immunol, 146, pp.330~338 (2006)[DOI]
- Yamamoto M, "IL-6 is required for the development of Th1 cell-mediated murine colitis", J Immunol, 164, pp.4878~4882 (2000)[DOI]
- Kuhn R, "Interleukin-10-deficient mice develop chronic enterocolitis", Cell, 75, pp.263~274 (1993)[DOI]
- Hirano T, "Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors", Oncogene, 19, pp.2548~2556 (2000)[DOI]
- Kanda N, "STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells", Oncogene, 23, pp.4921~4929 (2004)[DOI]
- Durant L, "Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis", Immunity, 32, pp.605~615 (2010)[DOI]
- Lee JK, "Signal transducer and activator of transcription 3 (Stat3) contributes to T-cell homeostasis by regulating pro-survival Bcl-2 family genes", Immunology, 140, pp.288~300 (2013)
- Niemand C, "Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3", J Immunol, 170, pp.3263~3272 (2003)[DOI]
- Hodge DR, "The role of IL-6 and STAT3 in inflammation and cancer", Eur J Cancer, 41, pp.2502~2512 (2005)[DOI]
- Lee MJ, "Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis", PLoS One, 7, pp.e38801~ (2012)[DOI]
- Xu L, "Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous <TEX>$TGF-{\beta}$<", TEX>, 2007, pp.178, 6725~6729
- Korn T, "IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells", Proc Natl Acad Sci U S A, 105, pp.18460~18465 (2008)[DOI]
- Baumgart DC, "Inflammatory bowel disease: cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)[DOI]
- Geremia A, "Innate and adaptive immunity in inflammatory bowel disease", Autoimmun Rev, 13, pp.3~10 (2014)[DOI]
- Hall LJ, "Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis", Dig Dis Sci, 56, pp.79~89 (2011)[DOI]
- Maloy KJ, "Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells", Immunol Lett, 97, pp.189~192 (2005)[DOI]
- Nancey S, "CD8+ cytotoxic T cells induce relapsing colitis in normal mice", Gastroenterology, 131, pp.485~496 (2006)[DOI]
- Nanno M, "Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor <TEX>${\alpha}$<", TEX> mutant mice, 2008, pp.134, 481~490
- Yu CR, "STAT3 regulates proliferation and survival of CD8+ T cells: enhances effector responses to HSV-1 infection, and inhibits IL-10+ regulatory CD8+ T cells in autoimmune uveitis", Mediators Inflamm, 2013, pp.359674~ (2013)
- Iyer SS, "Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease", Crit Rev Immunol, 32, pp.23~63 (2012)[DOI]
- Li B, "IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis", Mucosal Immunol, 7, pp.869~878 (2014)[DOI]
- Chaudhry A, "CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner", Science, 326, pp.986~991 (2009)[DOI]